EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Antibacterial Activity of Ceftriaxone–Clavulanic Acid and Ceftazidime–Clavulanic Acid Combinations Against Selected Bacterial Pathogens

Hayder Ahmed Kadhim, Anas Alkhouri, Israa Zorab, Hiba Ghanim, Hauda Abdulrahman, Mina Mazin, Aman Kawes

Adolescência e Saúde · 01.08.2026 · 21 (5s) · 357-370

DOI: 10.67440/ahj.v21i2.1253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Adolescência e Saúde, online erschienen am 01.08.2026. Verfasst von Hayder Ahmed Kadhim und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapy using a β-lactam antibiotic and a β-lactamase inhibitor may enhance effectiveness against resistant bacteria. This study examined the pharmacology and potential synergism of ceftriaxone-clavulanic acid and ceftazidime-clavulanic acid against Escherichia coli and Pseudomonas aeruginosa. Antibacterial efficacy was evaluated using the disk diffusion method across 32 Petri dishes — 16 per bacterial strain. Each strain's dishes were divided equally among four treatments: ceftriaxone (CX), ceftriaxone-clavulanate (CXC), ceftazidime (CT), and ceftazidime-clavulanate (CTX). Plates were incubated at 37°C for 18–24 hours, then assessed for zones of bacterial inhibition. Against E. coli, ceftriaxone alone showed greater activity than ceftazidime alone (mean: 12.5 vs. 1.75). Clavulanic acid enhanced both, with ceftazidime-clavulanate achieving the highest inhibition (mean = 20). Both combinations proved equally effective overall. Against P. aeruginosa, ceftriaxone again outperformed ceftazidime alone (mean: 17.25 vs. 4.00). Clavulanic acid did not significantly enhance ceftriaxone, but dramatically potentiated ceftazidime (mean: 4.00 to 21.5). Both clavulanate combinations were equally effective against this strain as well. These findings reinforce the value of β-lactam/β-lactamase inhibitor combination therapy for infections caused by E. coli and P. aeruginosa. Despite differences in standalone potency, clavulanic acid effectively equalized the performance of both antibiotics, highlighting the importance of synergy testing in guiding optimal antibiotic treatment.

Zitieren

APA

Kadhim, H. A., Alkhouri, A., Zorab, I., Ghanim, H., Abdulrahman, H., Mazin, M., & Kawes, A. (2026). Synergistic Antibacterial Activity of Ceftriaxone–Clavulanic Acid and Ceftazidime–Clavulanic Acid Combinations Against Selected Bacterial Pathogens. Adolescência e Saúde, 21(5s), 357-370. https://doi.org/10.67440/ahj.v21i2.1253

Vancouver

Kadhim HA, Alkhouri A, Zorab I, Ghanim H, Abdulrahman H, Mazin M, et al. Synergistic Antibacterial Activity of Ceftriaxone–Clavulanic Acid and Ceftazidime–Clavulanic Acid Combinations Against Selected Bacterial Pathogens. Adolescência e Saúde. 2026;21(5s):357-370. doi:10.67440/ahj.v21i2.1253

BibTeX
@article{Kadhim2026,
  author = {Kadhim, Hayder Ahmed and Alkhouri, Anas and Zorab, Israa and Ghanim, Hiba and Abdulrahman, Hauda and Mazin, Mina and Kawes, Aman},
  title = {Synergistic Antibacterial Activity of Ceftriaxone–Clavulanic Acid and Ceftazidime–Clavulanic Acid Combinations Against Selected Bacterial Pathogens},
  journal = {Adolescência e Saúde},
  year = {2026},
  volume = {21},
  number = {5s},
  pages = {357--370},
  doi = {10.67440/ahj.v21i2.1253}
}
Kostenlos starten →